Yahoo Finance11h
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
The trial will evaluate the safety, effectiveness and ability of the shot, dubbed mRNA-1403, to induce an immune response ...
The Victoria Advocate20d
Moderna R&D Day Highlights Progress and Strategic Priorities
[10] A Phase 1 trial designed to evaluate the safety, reactogenicity and immunogenicity of a trivalent norovirus vaccinecandidate, mRNA-1403, in participants 18 to 49 years of age and 60 to 80 ...
TheDerrick.com1d
Movie armorer's conviction upheld in fatal ‘Rust’ set shooting by Alec Baldwin
A judge has rejected a request to throw out the conviction of a movie armorer in the fatal shooting of a cinematographer by ...
Moderna, Inc.: Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...